The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Recombinant DNA Technology-Global Market Insights and Sales Trends 2025
Synopsis
The global Recombinant DNA Technology market size is expected to reach US$ 5388.6 million by 2029, growing at a CAGR of 8.6% from 2023 to 2029. The market is mainly driven by the significant applications of Recombinant DNA Technology in various end use industries. The expanding demands from the Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes and Others,, are propelling Recombinant DNA Technology market. Therapeutic Agent, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Recombinant DNA Technology market, driven by demand from China, the second largest economy with some signs of stabilising, the Recombinant DNA Technology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant DNA Technology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Recombinant DNA Technology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Recombinant DNA Technology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant DNA Technology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Recombinant DNA Technology covered in this report include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc.
The global Recombinant DNA Technology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Global Recombinant DNA Technology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant DNA Technology market, Segment by Type:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Global Recombinant DNA Technology market, by Application
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Recombinant DNA Technology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Recombinant DNA Technology market size is expected to reach US$ 5388.6 million by 2029, growing at a CAGR of 8.6% from 2023 to 2029. The market is mainly driven by the significant applications of Recombinant DNA Technology in various end use industries. The expanding demands from the Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes and Others,, are propelling Recombinant DNA Technology market. Therapeutic Agent, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vaccine segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Recombinant DNA Technology market, driven by demand from China, the second largest economy with some signs of stabilising, the Recombinant DNA Technology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Recombinant DNA Technology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Recombinant DNA Technology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Recombinant DNA Technology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Recombinant DNA Technology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Recombinant DNA Technology covered in this report include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc.
The global Recombinant DNA Technology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Global Recombinant DNA Technology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant DNA Technology market, Segment by Type:
Therapeutic Agent
Vaccine
Biotech Crops
Specialty Chemicals
Global Recombinant DNA Technology market, by Application
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Recombinant DNA Technology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Recombinant DNA Technology
1.1 Recombinant DNA Technology Market Overview
1.1.1 Recombinant DNA Technology Product Scope
1.1.2 Recombinant DNA Technology Market Status and Outlook
1.2 Global Recombinant DNA Technology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Recombinant DNA Technology Market Size by Region (2018-2029)
1.4 Global Recombinant DNA Technology Historic Market Size by Region (2018-2023)
1.5 Global Recombinant DNA Technology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Recombinant DNA Technology Market Size (2018-2029)
1.6.1 North America Recombinant DNA Technology Market Size (2018-2029)
1.6.2 Europe Recombinant DNA Technology Market Size (2018-2029)
1.6.3 Asia-Pacific Recombinant DNA Technology Market Size (2018-2029)
1.6.4 Latin America Recombinant DNA Technology Market Size (2018-2029)
1.6.5 Middle East & Africa Recombinant DNA Technology Market Size (2018-2029)
2 Recombinant DNA Technology Market by Type
2.1 Introduction
2.1.1 Therapeutic Agent
2.1.2 Vaccine
2.1.3 Biotech Crops
2.1.4 Specialty Chemicals
2.2 Global Recombinant DNA Technology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Recombinant DNA Technology Historic Market Size by Type (2018-2023)
2.2.2 Global Recombinant DNA Technology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Recombinant DNA Technology Revenue Breakdown by Type (2018-2029)
3 Recombinant DNA Technology Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology and Pharmaceutical Companies
3.1.2 Academic & Government Research Institutes
3.1.3 Others
3.2 Global Recombinant DNA Technology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Recombinant DNA Technology Historic Market Size by Application (2018-2023)
3.2.2 Global Recombinant DNA Technology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Recombinant DNA Technology Revenue Breakdown by Application (2018-2029)
4 Recombinant DNA Technology Competition Analysis by Players
4.1 Global Recombinant DNA Technology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant DNA Technology as of 2022)
4.3 Date of Key Players Enter into Recombinant DNA Technology Market
4.4 Global Top Players Recombinant DNA Technology Headquarters and Area Served
4.5 Key Players Recombinant DNA Technology Product Solution and Service
4.6 Competitive Status
4.6.1 Recombinant DNA Technology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Monsanto Company
5.1.1 Monsanto Company Profile
5.1.2 Monsanto Company Main Business
5.1.3 Monsanto Company Recombinant DNA Technology Products, Services and Solutions
5.1.4 Monsanto Company Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.1.5 Monsanto Company Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Recombinant DNA Technology Products, Services and Solutions
5.2.4 Roche Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Biogen
5.3.1 Biogen Profile
5.3.2 Biogen Main Business
5.3.3 Biogen Recombinant DNA Technology Products, Services and Solutions
5.3.4 Biogen Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.3.5 Amgen Recent Developments
5.4 Amgen
5.4.1 Amgen Profile
5.4.2 Amgen Main Business
5.4.3 Amgen Recombinant DNA Technology Products, Services and Solutions
5.4.4 Amgen Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.4.5 Amgen Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Recombinant DNA Technology Products, Services and Solutions
5.5.4 Novartis Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Eli Lilly and Company
5.6.1 Eli Lilly and Company Profile
5.6.2 Eli Lilly and Company Main Business
5.6.3 Eli Lilly and Company Recombinant DNA Technology Products, Services and Solutions
5.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly and Company Recent Developments
5.7 GenScript
5.7.1 GenScript Profile
5.7.2 GenScript Main Business
5.7.3 GenScript Recombinant DNA Technology Products, Services and Solutions
5.7.4 GenScript Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.7.5 GenScript Recent Developments
5.8 Pfizer Inc.
5.8.1 Pfizer Inc. Profile
5.8.2 Pfizer Inc. Main Business
5.8.3 Pfizer Inc. Recombinant DNA Technology Products, Services and Solutions
5.8.4 Pfizer Inc. Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Inc. Recent Developments
5.9 Novo Nordisk
5.9.1 Novo Nordisk Profile
5.9.2 Novo Nordisk Main Business
5.9.3 Novo Nordisk Recombinant DNA Technology Products, Services and Solutions
5.9.4 Novo Nordisk Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.9.5 Novo Nordisk Recent Developments
5.10 Sanofi
5.10.1 Sanofi Profile
5.10.2 Sanofi Main Business
5.10.3 Sanofi Recombinant DNA Technology Products, Services and Solutions
5.10.4 Sanofi Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.10.5 Sanofi Recent Developments
5.11 Merck KGaA
5.11.1 Merck KGaA Profile
5.11.2 Merck KGaA Main Business
5.11.3 Merck KGaA Recombinant DNA Technology Products, Services and Solutions
5.11.4 Merck KGaA Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.11.5 Merck KGaA Recent Developments
5.12 Profacgen
5.12.1 Profacgen Profile
5.12.2 Profacgen Main Business
5.12.3 Profacgen Recombinant DNA Technology Products, Services and Solutions
5.12.4 Profacgen Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.12.5 Profacgen Recent Developments
5.13 Biocon
5.13.1 Biocon Profile
5.13.2 Biocon Main Business
5.13.3 Biocon Recombinant DNA Technology Products, Services and Solutions
5.13.4 Biocon Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.13.5 Biocon Recent Developments
5.14 GlaxoSmithKline
5.14.1 GlaxoSmithKline Profile
5.14.2 GlaxoSmithKline Main Business
5.14.3 GlaxoSmithKline Recombinant DNA Technology Products, Services and Solutions
5.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.14.5 GlaxoSmithKline Recent Developments
5.15 Cibus
5.15.1 Cibus Profile
5.15.2 Cibus Main Business
5.15.3 Cibus Recombinant DNA Technology Products, Services and Solutions
5.15.4 Cibus Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.15.5 Cibus Recent Developments
5.16 Horizon Discovery Group
5.16.1 Horizon Discovery Group Profile
5.16.2 Horizon Discovery Group Main Business
5.16.3 Horizon Discovery Group Recombinant DNA Technology Products, Services and Solutions
5.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.16.5 Horizon Discovery Group Recent Developments
5.17 New England Biolabs
5.17.1 New England Biolabs Profile
5.17.2 New England Biolabs Main Business
5.17.3 New England Biolabs Recombinant DNA Technology Products, Services and Solutions
5.17.4 New England Biolabs Recombinant DNA Technology Revenue (US$ Million) & (2018-2023)
5.17.5 New England Biolabs Recent Developments
6 North America
6.1 North America Recombinant DNA Technology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Recombinant DNA Technology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA Technology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Recombinant DNA Technology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA Technology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Recombinant DNA Technology Market Dynamics
11.1 Recombinant DNA Technology Industry Trends
11.2 Recombinant DNA Technology Market Drivers
11.3 Recombinant DNA Technology Market Challenges
11.4 Recombinant DNA Technology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
